Search
for
Sort by
Research 211–240 of 719
- How to distinguish medicalization from over-medicalization?
- Hirsutism: Diagnosis and management
- Psychodermatology
- Update on the dermatologic use of systemic glucocorticosteroids
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Anabolic-androgenic steroids and cardiovascular risk
- Psychocutaneous disease
- Effect of a nutritional supplement on hair loss in women
- Current evaluation of amenorrhea
- How to Speak Postmodern: Medicine, Illness, and Cultural Change
- Pharmacologic Therapy of Polycystic Ovary Syndrome
- Hypertensive crisis associated with St. John’s Wort
- Pregnancy and the Skin
- Interventions for female pattern hair loss
- Sex hormones and sarcopenia in older persons
- Period problems: disorders of menstruation in adolescents
- Effect of minoxidil on blood pressure and hemodynamics in severe hypertension
- Prognosis and Management of Congenital Hair Shaft Disorders with Fragility—Part I
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Telogen Effluvium
- Experimental and Clinical Pharmacology of<i>Ziziphus jujuba</i>Mills
- Foot shock stress prolongs the telogen stage of the spontaneous hair cycle in a non‐depilated mouse model
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.
- Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19
- Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
- Androgen treatment of postmenopausal women
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Hair growth promoting effect of white wax and policosanol from white wax on the mouse model of testosterone-induced hair loss
- Polycystic ovarian syndrome